Cognetivity Neurosciences Ltd (CGNSF PINK) stock market data APIs
$0.002
0(0%)
as of March 25, 2025
Cognetivity Neurosciences Ltd Financial Data Overview
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Prev. Close
0.002
Open
0.002
High
0.002
Low
0.002
52 wk Range
0.001-0.023
Market Cap
699 K
Shares Outstanding
89 589 K
Revenue
98 971
EPS
-0.017
Beta
-0.266
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cognetivity Neurosciences Ltd data using free add-ons & libraries
Get Cognetivity Neurosciences Ltd Fundamental Data
Cognetivity Neurosciences Ltd Fundamental data includes:
- Net Revenue: 98 971
- EBITDA: -4 232 298
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-12-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cognetivity Neurosciences Ltd News
New
Cognetivity Neurosciences provides update on 2021 corporate achievements
Company poised for rapid expansion in 2022 after highly successful 2021, in which it secured commercial deployments across three continents, US FDA registration and multiple awards for innovation in A...
Former Director of Research at Alzheimer's Research UK Carol Routledge joins advisory board at Cognetivity Neurosciences
Dr Routledge brings extensive experience in senior roles at leading multinational pharmaceutical companies, as well as in the nonprofit sector and specialist venture capital VANCOUVER, BC, June 22, 2...
Former Director of Research at Alzheimer's Research UK Carol Routledge joins advisory board at Cognetivity Neurosciences
Dr Routledge brings extensive experience in senior roles at leading multinational pharmaceutical companies, as well as in the nonprofit sector and specialist venture capital VANCOUVER, BC, June 22, 2...
CubeSmart Recognized as One of America’s Best Employers by Forbes
MALVERN, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE), the third-largest owner and operator of self-storage properties in the United States, has been recognized as one of America’s...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
